Borderline resectable pancreatic cancer: definitions and the importance of multimodality therapy

Ann Surg Oncol. 2010 Nov;17(11):2803-5. doi: 10.1245/s10434-010-1285-8.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Adenocarcinoma / therapy
  • Antineoplastic Agents / administration & dosage
  • Combined Modality Therapy
  • Humans
  • Neoadjuvant Therapy*
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Pancreatic Neoplasms / therapy
  • Radiotherapy, Adjuvant

Substances

  • Antineoplastic Agents